https://scholars.lib.ntu.edu.tw/handle/123456789/503545
Title: | Emerging HIV-1 resistance to tipranavir and darunavir in patients with virological failure to first-generation protease inhibitors in Taiwan | Authors: | SZU-MIN HSIEH SUI-YUAN CHANG CHIEN-CHING HUNG WANG-HUEI SHENG Chen M.-Y. SHAN-CHWEN CHANG |
Issue Date: | 2011 | Journal Volume: | 22 | Journal Issue: | 11 | Start page/Pages: | 617-620 | Source: | International Journal of STD and AIDS | Abstract: | Ritonavir-boosted tipranavir (TPV/r) and darunavir (DRV/r) have been approved in patients with virological resistance to multiple protease inhibitors (PIs). Whether the HIV-1 from these patients with virological failure to first-generation PIs remains susceptible to TPV/r or DRV/r is questionable. The susceptibilities of HIV-1 isolates to second-generation PIs in patients who experienced virological failure in three time periods were analysed: 9-2006 to 4-2007 (period 1), 5-2007 to 12-2007 (period 2) and 1-2008 to 8-2008 (period 3). A total of 53 subjects were enrolled, and 51 subject isolates (96.2%) were resistant to ?1 PIs. The mutation scores for TPV and DRV, and the percentage of isolates with resistance to TPV or DRV, increased significantly from period 1 to period 3. Our data revealed a significant increase in the levels of genotypic resistance to TPV and DRV over the past two years in patients with virological failure to first-generation PIs. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/503545 | ISSN: | 0956-4624 | DOI: | 10.1258/ijsa.2009.009007 | SDG/Keyword: | darunavir; darunavir plus ritonavir; proteinase inhibitor; ritonavir plus tipranavir; tipranavir; adult; article; drug treatment failure; female; genotype; human; Human immunodeficiency virus 1; Human immunodeficiency virus 1 infection; major clinical study; male; nonhuman; priority journal; Taiwan; virus isolation; virus resistance; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Female; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Mutation, Missense; Pyridines; Pyrones; Sulfonamides; Taiwan; Treatment Failure |
Appears in Collections: | 醫學檢驗暨生物技術學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.